未登录

M

Min Ja Lee

center for foot-and-mouth disease vaccine research

H指数:16

被引数:689

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral levamisole as a route-decoupled adjunct to intramuscular foot-and-mouth disease vaccination: a two-species evaluation

口服左旋咪唑作为肌肉注射口蹄疫疫苗接种的途径解耦辅助剂：一种双物种评估

Frontiers in Veterinary Science

IF2.9

2026-09-240

OAAI

Engineered virus-like particle nanoplatforms for next-generation vaccines: antigen display, immune potentiation, and physicochemical stabilization

工程化病毒样颗粒纳米平台用于下一代疫苗：抗原展示、免疫增强和理化稳定化

Journal of Nanobiotechnology

IF12.6

2026-09-120

OA

Development of a Chimeric Vaccine Providing Protection Against the Type A ASIA/Sea-97 FMDVs in East Asia

开发一种针对东亚地区A型ASIA/Sea-97 FMDV的嵌合疫苗，提供保护作用

Vaccines 2025, Vol. 13, Page 1104

IF3.4

2025-10-290

OAAI

Immunostimulatory effects of multiple short-hairpin RNAs enhance foot-and-mouth disease vaccine-induced humoral immunity

多种短发夹状RNA的免疫刺激效应增强了口蹄疫疫苗诱导的体液免疫

Antiviral Research

IF4

2025-05-270

PRE

Oral administration of glycyrrhizic acid with intramuscular injection of foot-and-mouth disease vaccine enhances the adaptive immune system

FRONTIERS IN MICROBIOLOGY

IF4.5

2025-02-190

OAAI

Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses

FRONTIERS IN MICROBIOLOGY

IF4.5

2025-01-080

OAAI

Next-generation adjuvant systems containing furfurman drives potent adaptive immunity and host defense as a foot-and-mouth disease vaccine adjuvant

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-12-110

OAAI

Oral Administration of Zinc Sulfate with Intramuscular Foot-and-Mouth Disease Vaccine Enhances Mucosal and Systemic Immunity

IF3.4

2024-11-090

OAAI

D-galacto-D-mannan-mediated Dectin-2 activation orchestrates potent cellular and humoral immunity as a viral vaccine adjuvant

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-162

OAAI

Evaluation of a Vaccine Candidate Designed for Broad-Spectrum Protection against Type A Foot-and-Mouth Disease in Asia

IF3.4

2024-01-090

OAAI

Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines

IF3.4

2023-11-043

OAAI

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease

FRONTIERS IN MICROBIOLOGY

IF4.5

2023-10-316

OAAI

Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface

IF3.4

2023-09-140

OAAI

Dectin-1 signaling coordinates innate and adaptive immunity for potent host defense against viral infection

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-027

OAAI

Preventive effects of quercetin against foot-and-mouth disease virus in vitro and in vivo by inducing type I interferon

槲皮素通过诱导I型干扰素对口蹄疫病毒的体内外预防作用

FRONTIERS IN MICROBIOLOGY

IF4.5

2023-05-127

OAAI

Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O

IF3.4

2023-01-271

OAAI

The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity

IF6.5

2022-06-2811

OAAI

BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs

JOURNAL OF VIROLOGY

IF3.8

2022-06-227

OA

Age-Dependent Dynamics of Maternally Derived Antibodies (MDAs) and Understanding MDA-Mediated Immune Tolerance in Foot-and-Mouth Disease-Vaccinated Pigs

IF3.4

2022-04-246

OAAI

The Potential Adjuvanticity of CAvant(R)SOE for Foot-and-Mouth Disease Vaccine

CAvant(R)SOE对口蹄疫疫苗的潜在佐剂性

IF3.4

2021-09-285

OAAI